Predictors of long-term renal function after conversion to proliferation signal inhibitors in long-term heart transplant recipients

Journal of Heart and Lung Transplantation

Volumn 30, Issue 5, 2011, Pages 552-557

  González Vilchez, Francisco ^a   Vázquez De Prada, Jose A ^a   Castrillo, Cristina ^a   Canteli, Angela ^a   Llano, Miguel F ^a   Martín Durán, Rafael ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

everolimus; heart transplantation; renal function; sirolimus

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CREATININE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EVEROLIMUS; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CARDIAC GRAFT REJECTION; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DERMATITIS; DIABETES MELLITUS; DIARRHEA; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; EDEMA; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; GRAFT REJECTION; HEART TRANSPLANTATION; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; KIDNEY FUNCTION; LUNG TOXICITY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCINEURIN; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SIROLIMUS;

EID: 79953768918     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2010.11.005     Document Type: Article

References (21)

1. H. Valantine Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of the novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology J Heart Lung Transplant 26 2007 557 564 (Pubitemid 46818047)
2. D. Schmauss, and M. Weis Cardiac allograft vasculopathy Recent developments Circulation 117 2008 2131 2141 (Pubitemid 351596195)
3. J. Groetzner, I. Kaczmarek, and P. Landwehr Renal recovery after conversion to a calcineurin inhibitor-free immunosuppression in late cardiac transplant recipients Eur J Cardiothorac Surg 25 2004 333 341 (Pubitemid 38340566)
4. H. Lyster, G. Panicker, and N. Leaver Initial experience with sirolimus and mycophenolate mofetil for renal rescue from cyclosporine nephrotoxicity after heart transplantation Transplant Proc 36 2004 3167 3170 (Pubitemid 41126766)
5. S.S. Kushwaha, Z. Khalpey, and R.P. Frantz Sirolimus in cardiac transplantation: use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity J Heart Lung Transplant 24 2005 2129 2136 (Pubitemid 41814736)
6. C.A. Gleissner, A. Doesch, and P. Ehlermann Cyclosporine withdrawal improves renal function in heart transplant patients on reduced-dose cyclosporine therapy Am J Transplant 6 2006 2750 2758 (Pubitemid 44571697)
7. M. Rothenburger, E. Teerling, and C. Bruch Calcineurin inhibitorfree immunosuppression using everolimus (Certican) in maintenance heart transplant recipients: 6 months' follow-up J Heart Lung Transplant 26 2007 250 257 (Pubitemid 46341888)
8. F. Gustafsson, H.J. Ross, and M.S. Delgado Sirolimus-based immunosuppression after cardiac transplantation: predictors of recovery from calcineurin inhibitor-induced renal dysfunction J Heart Lung Transplant 26 2007 998 1003 (Pubitemid 47494663)
9. E. Raichlin, Z. Khalpey, and W. Kremers Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients Transplantation 84 2007 467 474 (Pubitemid 47312156)
10. J.A. Moro Lopez, L. Almenar, and L. Martnez-Dolz Progression of renal dysfunction in cardiac transplantation after the introduction of everolimus in the immunosuppressive regimen Transplantation 87 2009 538 541
11. J. Groetzner, I. Kaczmarek, and U. Schulz Mycophenolate and sirolimus as calcineurin inhibitor-free immunosuppression improves renal function better than calcineurin inhibitor-reduction in late cardiac transplant recipients with chronic renal failure Transplantation 87 2009 726 733
12. J. Moro, L. Almenar, and L. Martnez-Dolz mTOR inhibitors: do they help preserve renal function? Transplant Proc 39 2007 2135 2137 (Pubitemid 47418173)
13. A.Z. Aliabadi, E. Pohanka, and G. Seebacher Development of proteinuria after switch to sirolimus-based immunosuppression in long-term cardiac transplant patients Am J Transplant 8 2008 854 861 (Pubitemid 351347752)
14. S. Demirjian, B. Stephany, and I.S. Abu Romeh Conversion to sirolimus with calcineurin inhibitor elimination vs. dose minimization and renal outcome in heart and lung transplant recipients Clin Transplant 23 2009 351 360
15. M. Zakliczynski, J. Nozynski, and H. Zakliczynska Deterioration of renal function after replacement of cyclosporine with sirolimus in five patients with severe renal impairment late after heart transplantation Transplant Proc 35 2003 2331 2332 (Pubitemid 37194407)
16. A.S. Levey, T. Greene, and J.W. Kusek A simplified equation to predict glomerular filtration rate from serum creatinine [abstract] J Am Soc Nephrol 11 2000 155A
17. G.M. Fitzmaurice, and C. Ravichandran A primer in longitudinal data analysis Circulation 118 2008 2005 2010
18. M. Fernndez-Valls, F. Gonzlez-Vlchez, and J.A. Vazquez de Prada Use of sirolimus as an alternative to anticalcineurinic therapy in heart transplantation Experience of a single center Transplant Proc 37 2005 4012 4023
19. S.M. Flechner, J. Kobashigawa, and K. Goran Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity Clin Transplant 22 2008 1 15 (Pubitemid 351149996)
20. A.Z. Aliabadi, E. Pohanka, and D. Dunkler Impact of ACE-inhibitor and angiotensin receptor blocker therapy on development of proteinuria after switch to sirolimus in cardiac transplant recipients [abstract] J Heart Lung Transplant 27 suppl 2008 S67
21. E. Gude, L. Gullestad, and S. Arora Benefit of early conversion from CNI-based to everolimus-based immunosuppression in heart transplantation J Heart Lung Transplant 29 2010 641 647